{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:05:09Z","timestamp":1764173109850},"reference-count":18,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":479,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2000,9]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>High rates of <jats:italic>Helicobacter pylori<\/jats:italic> eradication can be achieved by combining proton pump inhibitors with two antibiotics. However, in the search for an optimal therapy a direct comparison of different regimens is necessary.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>For this open study, 331 patients with duodenal ulcer were screened and randomly allocated to either pantoprazole 40\u2003mg b.d., clarithromycin 500\u2003mg b.d., and metronidazole 500\u2003mg b.d. (PCM) or pantoprazole 40\u2003mg b.d., amoxycillin 1000\u2003mg b.d., and clarithromycin 500\u2003mg b.d. (PAC) for 7\u2003days. Both combinations were followed by a 7\u2010day therapy with pantoprazole 40\u2003mg o.d. alone. Eradication of <jats:italic>H. pylori<\/jats:italic> was assessed by use of a <jats:sup>13<\/jats:sup>C\u2010urea breath test 4\u2003weeks after the intake of the last medication.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Eradication rates were 90% in intention\u2010to\u2010treat patients from the PCM (132 out of 147; 95% CI: 84\u201394%) and the PAC group (135 out of 150; 95% CI: 84\u201394%). <jats:italic>H. pylori<\/jats:italic> was eradicated in 112 out of 117 per protocol patients of the PCM group (96%; 95% CI: 90\u201399%) and in 119 out of 126 patients of the PAC group (94%; 95% CI: 89\u201398%). Rapid relief from ulcer pain and a decrease in the mean intensity of other gastrointestinal symptoms was observed. Sixty\u2010nine patients reported adverse events, none of which were related to the intake of pantoprazole. Four serious adverse events, none related to the trial medication, were observed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>Both pantoprazole\u2010based short\u2010term triple therapies are highly effective and well\u2010tolerated treatment regimens in the eradication of <jats:italic>H. pylori<\/jats:italic>.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.2000.00827.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:42:16Z","timestamp":1047354136000},"page":"1151-1157","source":"Crossref","is-referenced-by-count":13,"title":["Eradication of <i>Helicobacter pylori<\/i> with pantoprazole and two antibiotics: a comparison of two short\u2010term regimens"],"prefix":"10.1111","volume":"14","author":[{"family":"Frevel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Daake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Janisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Kellner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Krezdorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Tanneberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Wack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.1.8"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529309098287"},{"key":"e_1_2_6_4_2","first-page":"129","article-title":"The impact of Helicobacter pylori infection in peptic ulcer disease: current practice and future perspectives","volume":"9","author":"Malfertheiner P","year":"1997","journal-title":"Eur J Clin Res"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00027.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.727119000.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.95267000.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1998.459_a.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-5378.2000.00006.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00660.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00354.x"},{"key":"e_1_2_6_12_2","first-page":"A93","article-title":"Double blind study comparing once daily versus twice daily dosage of PPI with amoxycillin clarithromycin for H. pylori cure","volume":"41","author":"Lamouliatte H","year":"1997","journal-title":"Gut"},{"key":"e_1_2_6_13_2","first-page":"886","article-title":"Pantoprazole\u2010based dual and triple therapy for the eradication of Helicobacter pylori infection: a randomized controlled trial","volume":"44","author":"Svoboda P","year":"1997","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)80435-6"},{"key":"e_1_2_6_15_2","first-page":"236","article-title":"Comparison of biopsy urease test and histologic examination for detection of Campylobacter pylori in duodenal, antral and fundic biopsies","volume":"34","author":"B\u00f6rsch G","year":"1987","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1159\/000201366"},{"key":"e_1_2_6_17_2","unstructured":"HartungJ ElpeltB Kl\u00f6senerK\u2010H.Statistik Lehr\u2010 Und Handbuch Der Angewandten Statistik. Wien M\u00fcnchen: Oldenbourg 1987: 202\u20134."},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1997.tb00065.x"},{"key":"e_1_2_6_19_2","first-page":"835","article-title":"Efficacy and optimum dose of omeprazole in a 1\u2010week triple therapy regimen to eradicate Helicobacter pylori","volume":"7","author":"Moayyedi P","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00827.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00827.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2000.00827.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T18:47:29Z","timestamp":1697395649000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2000.00827.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["10.1046\/j.1365-2036.2000.00827.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2000.00827.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,9]]}}}